JFL Life Sciences Financials

NSE: JFLLIFE

₹9.80

₹-0.35 (-3.45%)

As on 03-Sep-2026 15:31IST

Market cap

₹32 Cr

Revenue (TTM)

₹131 Cr

P/E Ratio

4.8

P/B Ratio

0.7

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Operating Revenue	130.90	131.38	82.04	46.55	42.83	33.59
Total Income	130.98	131.45	82.05	47.06	44.47	34.48
Total Expenditure	119.03	119.67	73.84	41.97	38.90	28.23
EBITDA	11.87	11.71	8.20	4.58	3.93	5.36
Depreciation	1.13	1.08	0.99	0.44	0.43	0.37
EBIT	10.74	10.64	7.21	4.14	3.50	4.99
Interest	2.16	2.11	1.08	0.86	1.42	2.08
Other Income	0.08	0.07	0.01	0.51	1.64	0.89
Exceptional Items	--	--	--	--	--	--
Profit before Tax	8.66	8.60	6.14	3.79	3.72	3.80
Provision for Tax	1.90	2.20	1.98	0.49	0.91	0.99
Profit after Tax	6.77	6.40	4.16	3.30	2.81	2.81

Liabilities (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Shareholder's Funds	45.87	45.87	39.46	35.58	32.27	11.29
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.39	7.39	0.84	0.39	1.67	8.59
Current Liabilities	52.99	52.99	31.62	20.63	15.12	28.38
Total Liabilities	106.25	106.25	71.91	56.71	49.06	48.26

Assets (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Non-Current Assets	11.95	14.75	12.41	12.99	7.92	8.96
Current Assets	91.50	91.50	59.50	43.60	41.14	39.30
Total Assets	106.25	106.25	71.91	56.71	49.06	48.26
Total Debt*	--	21.73	10.59	5.69	7.18	15.85
Net Current Assets	38.51	38.51	27.88	22.97	26.02	10.92
Contingent Liabilities	--	1.34	1.34	--	--	--

Cashflow (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Cash From Operating Activities	--	-4.33	-3.56	8.41	-9.07	2.32
Cash Flow from Investing Activities	--	-3.94	0.02	-6.09	0.87	-0.71
Cash from Financing Activities	--	9.10	3.54	-2.35	8.07	-1.46
Net Cash Inflow / Outflow	--	0.83	0.00	-0.03	-0.13	0.15

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Adjusted EPS (₹)	2.05	1.94	1.26	1.00	0.85	1.17
Cash EPS (₹)	--	2.27	1.56	1.13	0.98	1.32
Adjusted Book Value (₹)	--	13.90	11.96	10.78	9.78	4.69
Dividend per Share (₹)	--	--	--	0.08	--	--
Cash Flow per Share (₹)	--	-1.31	-1.08	7.65	-8.25	2.89
Free Cash Flow per Share (₹)	--	-3.62	-1.81	0.94	-9.46	-3.19

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
ROCE (%)	--	18.20	15.81	11.53	15.45	23.14
ROE (%)	15.37	15.00	11.08	9.73	12.90	30.94
ROA (%)	7.60	7.19	6.47	6.25	5.77	7.27
EBIT Margin (%)	8.21	8.10	8.78	8.89	8.18	14.86
Net Margin (%)	5.17	4.87	5.07	7.01	6.32	8.15
Cash Profit Margin (%)	--	5.69	6.28	8.04	7.55	9.47

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Revenue Growth (%)	55.69	60.14	76.25	8.68	27.50	2.49
EBIT Growth (%)	77.82	47.59	74.11	18.19	-29.82	164.58
Net Profit Growth (%)	124.11	53.96	25.98	17.47	-0.01	418.35
EPS Growth (%)	14.34	53.96	25.97	17.48	-27.09	317.59
Book Value Growth (%)	--	16.26	10.91	10.25	185.81	64.28

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Price / Earnings	4.78	4.41	13.85	4.37	4.31	--
Price / Book Value	0.69	0.62	1.46	1.22	1.12	--
Dividend Yield (%)	--	--	--	0.64	--	--
EV/EBITDA	4.40	4.12	8.30	9.52	7.80	3.79
Close Price (₹)	9.00	8.55	16.66	12.52	10.50	--
High Price (₹)	16.85	21.19	35.46	17.82	22.27	--
Low Price (₹)	8.55	8.55	11.77	10.34	9.58	--
Market Cap (₹ Cr)	32.34	28.21	57.58	43.28	36.29	--

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debt to Equity	0.15	0.47	0.27	0.16	0.22	1.40
Short term debt to equity ratio	--	0.30	0.25	0.13	0.18	0.48
Current Ratio	1.73	1.73	1.88	2.11	2.72	1.38
Quick Ratio	1.07	1.07	1.15	1.35	1.88	0.86
Interest Coverage	5.01	5.08	6.67	5.41	3.61	2.83

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debtors to sales (%)	40.69	40.54	42.59	55.53	52.48	58.95
Asset Turnover	1.47	1.47	1.28	0.88	0.88	0.87
Receivable days	--	122.52	135.23	189.47	180.15	171.72
Inventory Days	--	80.27	86.92	111.97	117.97	112.44
Payable days	--	74.66	83.56	90.91	116.67	141.53
Cash Conversion Cycle	--	128.13	138.58	210.52	181.46	142.63

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)